1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Chromatic Pupillometry in Isolated Rapid Eye Movement Sleep Behavior Disorder

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Melanopsin retinal ganglion cell (mRGC)‐mediated pupillary light reflex (PLR) abnormalities have been documented in several neurodegenerative disorders including Parkinson's disease. Overall, isolated rapid eye movement (REM) sleep behavior disorder (iRBD) represents the strongest prodromal risk factor for impending α‐synucleinopathies.

          Objectives

          To quantitatively compare PLR and mRGC‐mediated contribution to PLR in 16 iRBD patients and 16 healthy controls.

          Methods

          iRBD and controls underwent extensive neuro‐ophthalmological evaluation and chromatic pupillometry. In iRBD, PLR metrics were correlated with clinical variables and with additional biomarkers including REM atonia index (RAI), DaTscan, and presence of phosphorylated‐α‐synuclein (p‐α‐syn) deposition in skin biopsy.

          Results

          We documented higher baseline pupil diameter and decreased rod‐transient PLR amplitude in iRBD patients compared to controls. PLR rod‐contribution correlated with RAI. Moreover, only iRBD patients with evidence of p‐α‐syn deposition at skin biopsy showed reduced PLR amplitude compared to controls.

          Conclusion

          The observed PLR abnormalities in iRBD might be considered as potential biomarkers for the risk stratification of phenoconversion of the disease. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Book: not found

          International Classification of Sleep Disorders

          "The International Classification of Sleep Disorders - Third Edition (ICSD-3) is the authoritative clinical text for the diagnosis of sleep disorders. This is an essential reference for all clinicians with sleep disorders patients. Updated in 2014, the third revision to the ICSD features significant content changes, including new nomenclature, classifications and diagnoses. The book also features accurate diagnostic codes for the corresponding ICD-9 and ICD-10 diagnoses at the beginning of each diagnosis section of the ICSD-3. Disorders are grouped into six major categories: Insomnia ; Sleep Related Breathing Disorders ; Central Disorders of Hypersomnolence ; Circadian Rhythm Sleep-Wake Disorders ; Parasomnias ; Sleep Related Movement Disorders." --
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

            See Morris and Weil (doi:10.1093/brain/awz014) for a scientific commentary on this article. In a prospective multicentre study involving 1280 patients with idiopathic RBD, Postuma et al. show that approximately 6% of patients each year (>73.5% over 12 years) convert to full neurodegenerative disease. They test the predictive power of 21 prodromal markers of neurodegeneration, providing a template for planning neuroprotective trials.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Idiopathic REM sleep behaviour disorder and neurodegeneration — an update

              So-called idiopathic rapid eye movement (REM) sleep behaviour disorder (RBD), formerly seen as a rare parasomnia, is now recognized as the prodromal stage of an α-synucleinopathy. Given the very high risk that patients with idiopathic RBD have of developing α-synucleinopathies, such as Parkinson disease (PD), PD dementia, dementia with Lewy bodies or multiple system atrophy, and the outstandingly high specificity and very long interval between the onset of idiopathic RBD and the clinical manifestations of α-synucleinopathies, the prodromal phase of this disorder represents a unique opportunity for potentially disease-modifying intervention. This Review provides an update on classic and novel biomarkers of α-synuclein-related neurodegeneration in patients with idiopathic RBD, focusing on advances in imaging and neurophysiological, cognitive, autonomic, tissue-specific and other biomarkers. We discuss the strengths, potential weaknesses and suitability of these biomarkers for identifying RBD and neurodegeneration, with an emphasis on predicting progression to overt α-synucleinopathy. The role of video polysomnography in providing quantifiable and potentially treatment-responsive biomarkers of neurodegeneration is highlighted. In light of all these advances, and the now understood role of idiopathic RBD as an early manifestation of α-synuclein disease, we call for idiopathic RBD to be reconceptualized as isolated RBD.
                Bookmark

                Author and article information

                Contributors
                chiara.lamorgia@isnb.it
                Journal
                Mov Disord
                Mov Disord
                10.1002/(ISSN)1531-8257
                MDS
                Movement Disorders
                John Wiley & Sons, Inc. (Hoboken, USA )
                0885-3185
                1531-8257
                07 October 2021
                January 2022
                : 37
                : 1 ( doiID: 10.1002/mds.v37.1 )
                : 205-210
                Affiliations
                [ 1 ] IRCCS Istituto delle Scienze Neurologiche di Bologna UOC Clinica Neurologica Bologna Italy
                [ 2 ] Dipartimento di Scienze Biomediche e Neuromotorie Università di Bologna Bologna Italy
                [ 3 ] Department of Basic Medicine, Neuroscience, and Sense Organs University of Bari "Aldo Moro" Bari Italy
                [ 4 ] Center for Neurodegenerative Diseases and the Aging Brain University of Bari "Aldo Moro"‐ A.O. Pia Fondazione Cardinale G. Panico Tricase Italy
                [ 5 ] Department of Ophthalmology and Visual Sciences University of Illinois at Chicago Chicago Illinois USA
                [ 6 ] Dipartimento di Neuroscienze, Biomedicina e Movimento Università di Verona Verona Italy
                [ 7 ] Department of Biomedical, Metabolic and Neural Sciences University of Modena and Reggio Emilia Modena Italy
                Author notes
                [*] [* ] * Correspondence to: Dr. Chiara La Morgia, IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Via Altura 3, 40139, Bologna, Italia. E‐mail: chiara.lamorgia@ 123456isnb.it

                Author information
                https://orcid.org/0000-0002-4639-8929
                https://orcid.org/0000-0003-1995-558X
                https://orcid.org/0000-0001-9702-8314
                https://orcid.org/0000-0002-1290-7318
                https://orcid.org/0000-0003-1739-6139
                Article
                MDS28809
                10.1002/mds.28809
                9293298
                34617633
                46382b11-37ec-4d08-99dc-5526c5fcf32e
                © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 01 August 2021
                : 15 May 2021
                : 10 September 2021
                Page count
                Figures: 1, Tables: 1, Pages: 35, Words: 3774
                Categories
                Brief Report
                Regular Issue Articles
                Brief Reports
                Custom metadata
                2.0
                January 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:18.07.2022

                Medicine
                pupillometry,rem sleep behavior disorder,synucleinopathy,neurodegeneration,melanopsin
                Medicine
                pupillometry, rem sleep behavior disorder, synucleinopathy, neurodegeneration, melanopsin

                Comments

                Comment on this article